Revolution Medicines is dedicated to discovering, developing, and delivering innovative targeted medicines for cancer patients. The company focuses on RAS-addicted cancers, which represent 30 percent of new human cancer diagnoses. Revolutionaries work tirelessly to develop cutting-edge therapeutic approaches, setting them apart in the industry with their commitment to tackling some of the toughest cancers.
Revolution Medicines is seeking a Senior Director, HEOR/RWE to lead the development and execution of HEOR (Evidence-Based Research) strategies and activities related to their RAS(ON) Inhibitor assets, specifically targeting pancreatic and colorectal cancers. This role involves aligning with medical and marketing teams, delivering evidence to stakeholders, and advocating for the value of the company's products. The position requires a strategic mindset and strong communication skills.
Revolution Medicines is dedicated to discovering, developing, and delivering innovative targeted medicines for cancer patients. The company focuses on RAS-addicted cancers, which represent 30 percent of new human cancer diagnoses. Revolutionaries work tirelessly to develop cutting-edge therapeutic approaches, setting them apart in the industry with their commitment to tackling some of the toughest cancers.
Revolution Medicines